Real-world observations with dronedarone compared to other anti-arrhythmic drugs in recurrent atrial fibrillation.

Background : Many clinical trials have shown that dronedarone which is a potent ion channels blocker is effective in the prevention of atrial fibrillation (AF) relapses. Objective: The aim of this report is to evaluate the recurrence of AF and safety during therapy with dronedarone.